MCRBSeres Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Seres Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCRBThis | $42M#8 | — | 1.2x#4 | 53.4x#6 | — | 4088.2%#1 | -11910.1%#10 | 16.5%#1 | -72.9%#3 | — | -75.4%#5 | — |
| HYPD | $51M#1 | — | 0.5x#2 | 62.3x#8 | 1318.8%#1 | 9.0%#8 | -5743.5%#8 | -44.5%#3 | -46.8%#2 | — | — | — |
| CLNN | $50M#2 | — | — | 248.0x#10 | -41.5%#7 | 33.6%#4 | -11541.5%#9 | — | — | — | -39.1%#3 | — |
| VBIO | $47M#3 | — | 11.1x#11 | 60.3x#7 | -33.7%#6 | -57.0%#11 | -1012.6%#5 | -209.1%#8 | — | — | -97.3%#9 | — |
| ELTX | $47M#4 | — | 5.9x#9 | 20.2x#5 | -91.9%#8 | 23.8%#5 | -1639.0%#7 | -498.6%#11 | — | — | -84.3%#7 | — |
| HOWL | $46M#5 | — | 2.8x#8 | — | — | 13.7%#6 | — | -373.3%#9 | -229.9%#4 | — | -34.6%#1 | — |
| ANVS | $46M#6 | — | — | — | — | -17.3%#9 | — | — | — | — | -54.8%#4 | — |
| KAPA | $42M#7 | — | 10.1x#10 | — | — | -109.3%#12 | — | -130.0%#7 | — | — | -84.2%#6 | — |
| SDEV | $42M#9 | — | 0.3x#1 | 4.3x#4 | -6.4%#5 | -8632.9%#14 | -86.3%#3 | -495.7%#10 | -7.0%#1 | — | -91.5%#8 | 11.6%#1 |
| SCYX | $41M#10 | 14.8x#2 | 0.6x#3 | 2.0x#2 | 449.9%#2 | 59.6%#2 | -78.0%#2 | -12.9%#2 | — | 7#1 | — | — |
| ATNM | $40M#11 | 3.6x#1 | 1.3x#5 | 443.7x#11 | — | 11.4%#7 | -40274.4%#11 | -111.8%#6 | — | — | — | — |
| VERU | $40M#12 | — | 1.4x#6 | 2.4x#3 | 3.6%#3 | 39.9%#3 | -146.6%#4 | -80.1%#5 | -399.3%#5 | — | -36.3%#2 | 0.0%#2 |
| KPTI | $39M#13 | — | — | 0.3x#1 | 0.6%#4 | -156.5%#13 | -62.1%#1 | — | — | — | — | — |
| ELAB | $38M#14 | — | 2.3x#7 | 64.2x#9 | — | -24.0%#10 | -1304.4%#6 | -46.3%#4 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice